应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
YMAB Y-mAbs Therapeutics, Inc.
盘前交易 05-02 05:07:05 EDT
16.49
+1.28
+8.42%
最高
17.00
最低
15.36
成交量
36.53万
今开
15.36
昨收
15.21
日振幅
10.78%
总市值
7.23亿
流通市值
4.19亿
总股本
4,387万
成交额
595.85万
换手率
1.44%
流通股本
2,541万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.28%报15.96美元
自选股智能写手 · 04-23
Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.28%报15.96美元
Y-Mabs Therapeutics, Inc.盘中异动 股价大涨5.29%
自选股智能写手 · 04-11
Y-Mabs Therapeutics, Inc.盘中异动 股价大涨5.29%
Y-Mabs Therapeutics, Inc.盘中异动 下午盘快速下跌5.25%
自选股智能写手 · 04-04
Y-Mabs Therapeutics, Inc.盘中异动 下午盘快速下跌5.25%
Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.10%报16.50美元
自选股智能写手 · 03-28
Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.10%报16.50美元
Y-Mabs Therapeutics, Inc.盘中异动 早盘大幅拉升5.29%
自选股智能写手 · 03-21
Y-Mabs Therapeutics, Inc.盘中异动 早盘大幅拉升5.29%
Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大涨5.01%
自选股智能写手 · 03-19
Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大涨5.01%
BUZZ-首席财务官下台后,Y-mAbs Therapeutics 公司业绩下滑
Reuters · 03-14
BUZZ-首席财务官下台后,Y-mAbs Therapeutics 公司业绩下滑
Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报14.93美元
自选股智能写手 · 03-14
Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报14.93美元
Y-Mabs Therapeutics, Inc.盘中异动 大幅拉升5.08%报17.49美元
自选股智能写手 · 03-06
Y-Mabs Therapeutics, Inc.盘中异动 大幅拉升5.08%报17.49美元
Y-Mabs Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报16.46美元
自选股智能写手 · 03-06
Y-Mabs Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报16.46美元
加载更多
公司概况
公司名称:
Y-mAbs Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Y-mAbs Therapeutics, Inc.于2015年4月30日根据特拉华州法律注册成立。该公司是一家后期临床生物制药公司,专注于开发和将用于治疗癌症的新型抗体治疗产品商业化。YY-mAbs Therapeutics, Inc.拥有广泛而先进的产品系列,包括两个关键阶段产品候选物 - 纳西他马和omburtamab-分别针对与GD2和B7-H3相关的肿瘤。该公司正在开发用于治疗患有复发或难治性或R / R,高风险神经母细胞瘤或NB的儿科患者的naxitamab,以及用于治疗患有中枢神经系统或中枢神经系统,软脑膜转移瘤或LM的儿科患者的放射性标记的omburtamab来自NB。NB是在交感神经系统中发展的罕见且几乎完全是小儿的癌症,并且CNS / LM是NB的罕见且通常致命的并发症,其中疾病传播到CNS中的脑膜和脊髓周围的脑膜或脑膜。
发行价格:
--
{"stockData":{"symbol":"YMAB","market":"US","secType":"STK","nameCN":"Y-mAbs Therapeutics, Inc.","latestPrice":16.49,"timestamp":1714593600000,"preClose":15.21,"halted":0,"volume":365254,"delay":0,"floatShares":25412922,"shares":43872638,"eps":-0.490933,"marketStatus":"盘前交易","marketStatusCode":1,"change":1.28,"latestTime":"05-02 05:07:05 EDT","open":15.36,"high":17,"low":15.36,"amount":5958480.911262,"amplitude":0.107824,"askPrice":26.38,"askSize":200,"bidPrice":15.09,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.490933,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714656600000},"adr":0,"listingDate":1537502400000,"adjPreClose":16.49,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":16.49,"preClose":16.49,"latestTime":"19:44 EDT","volume":17707,"amount":291998.21,"timestamp":1714607085501},"volumeRatio":1.682086583405116},"requestUrl":"/m/hq/s/YMAB","defaultTab":"news","newsList":[{"id":"2429116801","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.28%报15.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429116801","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429116801?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:37","pubTimestamp":1713883027,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时37分,Y-Mabs Therapeutics, Inc.股票出现异动,股价急速上涨5.28%。截至发稿,该股报15.96美元/股,成交量18.4803万股,换手率0.42%,振幅6.56%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.55%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423223707861e8346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423223707861e8346&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426263626","title":"Y-Mabs Therapeutics, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426263626","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426263626?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:59","pubTimestamp":1712843974,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时59分,Y-Mabs Therapeutics, Inc.股票出现波动,股价急速拉升5.29%。截至发稿,该股报14.52美元/股,成交量4.2442万股,换手率0.10%,振幅3.99%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.72%。其相关个股中,Rallybio Corporation、Eliem Therapeutics, Inc、Alpine Immune Sciences, Inc.涨幅较大,Scisparc Ltd.、Aptevo Therapeutics Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为400.03%、355.75%、241.74%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Rallybio Corporation、Adial Pharmaceuticals, Inc,振幅分别为46.31%、44.79%、25.32%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411215934791ff1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411215934791ff1c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424822797","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424822797","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424822797?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:08","pubTimestamp":1712164091,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时08分,Y-Mabs Therapeutics, Inc.股票出现波动,股价急速下跌5.25%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,方舟生物医药、Kintara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃,换手率分别为531.72%、490.32%、76.72%,振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进,振幅分别为97.51%、58.48%、44.44%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040401081187e7dfc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040401081187e7dfc0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422955928","title":"Y-Mabs Therapeutics, Inc.盘中异动 快速拉升5.10%报16.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422955928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422955928?lang=zh_cn&edition=full","pubTime":"2024-03-28 03:42","pubTimestamp":1711568527,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日03时42分,Y-Mabs Therapeutics, Inc.股票出现波动,股价急速上涨5.10%。截至发稿,该股报16.50美元/股,成交量10.2447万股,换手率0.23%,振幅7.17%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Ibio, Inc.、Nutriband Inc C/Wts 、Moolec Science Sa C/Wts 涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为4682.81%、1351.03%、89.25%,振幅较大的相关个股有Ibio, Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为150.43%、80.26%、78.00%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032803420787e7c5cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032803420787e7c5cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421991046","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘大幅拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421991046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421991046?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:30","pubTimestamp":1711027849,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时30分,Y-Mabs Therapeutics, Inc.股票出现波动,股价急速拉升5.29%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Argenx Se、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大,Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Kazia Therapeutics Limited较为活跃,换手率分别为63.61%、13.81%、7.93%,振幅较大的相关个股有Immatics N.V.、Virpax Pharmaceuticals, Inc.、Context Therapeutics Inc.,振幅分别为7.03%、6.84%、6.08%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213050861e0166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213050861e0166&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420220948","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420220948","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420220948?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:55","pubTimestamp":1710856507,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时55分,Y-Mabs Therapeutics, Inc.股票出现异动,股价大幅上涨5.01%。截至发稿,该股报14.45美元/股,成交量12.4705万股,换手率0.28%,振幅4.87%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Fusion Pharmaceuticals Inc.、Hoth Therapeutics, Inc.、Enveric Biosciences, Inc.涨幅较大,Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为681.05%、239.46%、129.75%,振幅较大的相关个股有Enveric Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Clearmind Medicine Inc.,振幅分别为39.09%、30.00%、22.31%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921550787e7a13c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921550787e7a13c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419833819","title":"BUZZ-首席财务官下台后,Y-mAbs Therapeutics 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2419833819","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419833819?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:36","pubTimestamp":1710426963,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 3月14日 - ** 制药公司Y-mAbs Therapeutics 股价下跌6%,至14.88美元 ** 公司宣布自2015年4月成立以来一直担任首席财务官的Bo Kruse辞职** YMAB已开始寻找继任者 ** 克鲁泽将继续担任首席财务官,直至继任者确定 - YMAB** 包括盘中走势在内,该股在过去12个月中上涨了一倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419607977","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报14.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607977","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419607977?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:49","pubTimestamp":1710424162,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时49分,Y-Mabs Therapeutics, Inc.股票出现波动,股价大幅跳水5.78%。截至发稿,该股报14.93美元/股,成交量2.494万股,换手率0.06%,振幅2.40%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214922791a7c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214922791a7c6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417292392","title":"Y-Mabs Therapeutics, Inc.盘中异动 大幅拉升5.08%报17.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417292392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417292392?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:34","pubTimestamp":1709735666,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时34分,Y-Mabs Therapeutics, Inc.股票出现波动,股价大幅上涨5.08%。截至发稿,该股报17.49美元/股,成交量1.205万股,换手率0.03%,振幅1.86%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Biomx Inc.、知临集团、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Creative Medical Technology Holdings, Inc.、Biomx Inc.、知临集团较为活跃,换手率分别为162.07%、119.53%、95.80%,振幅较大的相关个股有Biomx Inc.、知临集团、Nkgen Biotech, Inc.,振幅分别为53.66%、48.27%、25.41%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030622342787e76823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030622342787e76823&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417592421","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报16.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417592421","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417592421?lang=zh_cn&edition=full","pubTime":"2024-03-06 04:01","pubTimestamp":1709668917,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日04时01分,Y-Mabs Therapeutics, Inc.股票出现异动,股价大幅下跌5.02%。截至发稿,该股报16.46美元/股,成交量13.9331万股,换手率0.32%,振幅4.73%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.53%。Y-Mabs Therapeutics, Inc.公司简介:Y-mAbs Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604015779178e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604015779178e95&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ymabs.com","stockEarnings":[{"period":"1week","weight":0.0785},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.2315},{"period":"6month","weight":2.0146},{"period":"1year","weight":1.7997},{"period":"ytd","weight":1.4179}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Y-mAbs Therapeutics, Inc.于2015年4月30日根据特拉华州法律注册成立。该公司是一家后期临床生物制药公司,专注于开发和将用于治疗癌症的新型抗体治疗产品商业化。YY-mAbs Therapeutics, Inc.拥有广泛而先进的产品系列,包括两个关键阶段产品候选物 - 纳西他马和omburtamab-分别针对与GD2和B7-H3相关的肿瘤。该公司正在开发用于治疗患有复发或难治性或R / R,高风险神经母细胞瘤或NB的儿科患者的naxitamab,以及用于治疗患有中枢神经系统或中枢神经系统,软脑膜转移瘤或LM的儿科患者的放射性标记的omburtamab来自NB。NB是在交感神经系统中发展的罕见且几乎完全是小儿的癌症,并且CNS / LM是NB的罕见且通常致命的并发症,其中疾病传播到CNS中的脑膜和脊髓周围的脑膜或脑膜。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053593},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.024313},{"month":3,"riseRate":0.5,"avgChangeRate":0.092289},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.000439},{"month":5,"riseRate":0.833333,"avgChangeRate":0.189299},{"month":6,"riseRate":0.6,"avgChangeRate":0.049794},{"month":7,"riseRate":0.2,"avgChangeRate":-0.060414},{"month":8,"riseRate":0.6,"avgChangeRate":0.041296},{"month":9,"riseRate":0.2,"avgChangeRate":-0.045617},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.11266},{"month":11,"riseRate":0.833333,"avgChangeRate":0.064156},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024264}],"exchange":"NASDAQ","name":"Y-mAbs Therapeutics, Inc.","nameEN":"Y-mAbs Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Y-mAbs Therapeutics, Inc.(YMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Y-mAbs Therapeutics, Inc.,YMAB,Y-mAbs Therapeutics, Inc.股票,Y-mAbs Therapeutics, Inc.股票老虎,Y-mAbs Therapeutics, Inc.股票老虎国际,Y-mAbs Therapeutics, Inc.行情,Y-mAbs Therapeutics, Inc.股票行情,Y-mAbs Therapeutics, Inc.股价,Y-mAbs Therapeutics, Inc.股市,Y-mAbs Therapeutics, Inc.股票价格,Y-mAbs Therapeutics, Inc.股票交易,Y-mAbs Therapeutics, Inc.股票购买,Y-mAbs Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Y-mAbs Therapeutics, Inc.(YMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}